Market Cap

Telix Pharmaceuticals Limited Market Capitalization:

A$6.07 Billion

AUD as of July 1, 2024

US$4.04 Billion

business Telix Pharmaceuticals Limited Company Profile

Telix Pharmaceuticals Limited Main Stock Listing

ASX: TLX

Market Capitalization History of Telix Pharmaceuticals Limited

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Telix Pharmaceuticals Limited market cap

Date Market Cap YoY Change
Jan. 1, 2024 A$3.09 B 53.66%
Jan. 1, 2023 A$2.01 B -3.83%
Jan. 1, 2022 A$2.09 B 77.28%
Jan. 31, 2021 A$1.18 B -1.29%
Jan. 1, 2021 A$1.20 B 196.18%
Jan. 31, 2020 A$403.6 M -11.49%
Jan. 1, 2020 A$456.0 M 106.99%
Jan. 31, 2019 A$220.3 M -1.38%
Jan. 1, 2019 A$223.4 M 34.26%
Jan. 31, 2018 A$166.4 M -6.90%
Jan. 1, 2018 A$178.7 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Telix Pharmaceuticals Limited Categories

Australia languages Healthcare languages Biotechnology
Australia Healthcare Australia Biotechnology

Stocks & Indices

Telix Pharmaceuticals Limited has the following listings and related stock indices.


Stock: ASX: TLX

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.